News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
START Midwest team has successfully dosed all three patients in the first cohort of the LOXO-FRA-24001 (J5E-OX-JZXA) trial
Photo from The START Center for Cancer Research/LinkedIn
Jun 23, 2024, 13:45

START Midwest team has successfully dosed all three patients in the first cohort of the LOXO-FRA-24001 (J5E-OX-JZXA) trial

The START Center for Cancer Research shared on LinkedIn:          .

“We are proud to announce that our START Midwest team has successfully dosed all three patients in the first cohort of the LOXO-FRA-24001 (J5E-OX-JZXA) trial.

This innovative study, in collaboration with Loxo@Lilly, evaluates an antibody drug conjugate targeting folate receptor alpha with a topoisomerase 1 inhibitor payload.

Dr. Nehal Lakhani, Director of Clinical Research at START Midwest, shares, ‘Dosing the first cohort in the LOXO-FRA-24001 trial marks a significant achievement for our team. This study exemplifies our ongoing commitment to pioneering advanced treatments in oncology.’

Read more about this study.”

Source: The START Center for Cancer Research/LinkedIn

ADCs antibody-drug conjugate cancer innovative study LOXO-FRA-24001 trial Loxo@Lilly Nehal Lakhani OncoDaily Oncology START Midwest
Special Coverage
Blog
Jan 15, 2025, 13:20
Aruni Ghose: Meeting Prof. Vanita Noronha and Celebrating Global Collaborations
Blog
Jan 15, 2025, 13:19
Komal Jhaveri: Participating in Dry January as a personal commitment to my health
Blog
Jan 15, 2025, 13:18
Dana-Farber Cancer Institute - One of the first clinical trials in the US to test 'memory like' NK cells in ovarian cancer
Science
Jan 15, 2025, 13:17
Myeloma Paper of the Day, January 15th, suggested by Robert Orlowski
Career
Jan 15, 2025, 13:16
OncoInfluencers to Follow on Social Media: Dr. Komal Jhaveri
Blog
Jan 15, 2025, 13:07
Yan Leyfman: Using routine blood tests to predict immunotherapy response across multiple cancers
Blog
Jan 15, 2025, 13:05
Douglas Flora: Association of Cancer Care Centers just pledged to match $10,000 in donations to Firefighter Cancer Support Network
Blog
Jan 15, 2025, 13:03
Ellen Sigal: Ready to get back to work and continue fighting to ensure every patient has access to the most innovative medicines
Blog
Jan 15, 2025, 13:00
Ray Bai: Methods and Applications for Bayesian Semiparametric Survival Analysis
Blog
Jan 15, 2025, 11:08
Why Dana-Farber Direct Connect? - Dana-Farber Cancer Institute
Blog
Jan 15, 2025, 10:56
Sachin H. Jain: The path forward for the US Health Insurance Industry begins with saying “We Are Sorry”
Blog
Jan 15, 2025, 08:23
Pashtoon Kasi: Different kind of liquid biopsies in guiding care of patients with cancer